Suppr超能文献

包含SUR2A或SUR2B亚基的K(ATP)通道对核苷酸和平那地尔的差异反应。

Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.

作者信息

Reimann F, Gribble F M, Ashcroft F M

机构信息

Oxford University Laboratory of Physiology, Oxford, UK.

出版信息

Mol Pharmacol. 2000 Dec;58(6):1318-25. doi: 10.1124/mol.58.6.1318.

Abstract

ATP-sensitive K-channels (K(ATP) channels) are the target for K(ATP)-channel openers (KCOs), such as pinacidil and P1075. These channels are formed from pore-forming Kir6.2 and regulatory sulfonylurea receptors (SUR2A in heart and skeletal muscle; SUR2B in smooth muscle). The two isoforms of SUR2 differ only in their final 42 amino acids, a region that includes neither the Walker A and B nucleotide binding motifs nor the proposed KCO binding site, yet channels containing SUR2A or SUR2B respond differently to both nucleotides and KCOs. We explored the basis for this difference by expressing Kir6.2/SUR2A and Kir6.2/SUR2B currents in Xenopus laevis oocytes. Kir6.2/SUR2B but not Kir6.2/SUR2A currents were activated by the Mg-nucleoside triphosphates MgATP and MgGTP, whereas both channel types responded to the diphosphates MgADP and MgGDP. This activation of Kir6.2/SUR2B currents by MgATP explains how the ATP concentration-response curve is shifted to the right in the presence of Mg(2+). In the absence of nucleotide, pinacidil and P1075 activated Kir6.2/SUR2B and Kir6.2/SUR2A currents, but the presence of nucleotide slowed the drug off-rates. In the presence of MgATP, the response to pinacidil reversed approximately 14 times more slowly with SUR2B than SUR2A. The EC(50) for ATP, measured by its ability to slow the pinacidil off-rate, was also approximately 20 times higher for channels containing SUR2A than SUR2B. Our findings suggest that nucleotide binding and/or hydrolysis is enhanced in SUR2B compared with SUR2A, and that the greater KCO-affinities of SUR2B compared with SUR2A may be a consequence of this altered nucleotide handling.

摘要

ATP敏感性钾通道(K(ATP)通道)是K(ATP)通道开放剂(KCOs)的作用靶点,如吡那地尔和P1075。这些通道由形成孔道的Kir6.2和调节性磺脲类受体组成(心脏和骨骼肌中为SUR2A;平滑肌中为SUR2B)。SUR2的两种同工型仅在其最后的42个氨基酸上有所不同,该区域既不包括沃克A和B核苷酸结合基序,也不包括推测的KCO结合位点,但含有SUR2A或SUR2B的通道对核苷酸和KCOs的反应不同。我们通过在非洲爪蟾卵母细胞中表达Kir6.2/SUR2A和Kir6.2/SUR2B电流来探究这种差异的基础。Kir6.2/SUR2B电流而非Kir6.2/SUR2A电流被Mg - 核苷三磷酸MgATP和MgGTP激活,而两种通道类型对二磷酸MgADP和MgGDP均有反应。MgATP对Kir6.2/SUR2B电流的这种激活解释了在Mg(2+)存在时ATP浓度 - 反应曲线如何向右移动。在无核苷酸的情况下,吡那地尔和P1075激活Kir6.2/SUR2B和Kir6.2/SUR2A电流,但核苷酸的存在减缓了药物解离速率。在MgATP存在时,SUR2B对吡那地尔的反应逆转速度比SUR2A慢约14倍。通过其减缓吡那地尔解离速率的能力测定的ATP的EC(50),对于含有SUR2A的通道也比对含有SUR2B的通道高约20倍。我们的研究结果表明,与SUR2A相比,SUR2B中的核苷酸结合和/或水解增强,并且与SUR2A相比,SUR2B对KCOs更高的亲和力可能是这种核苷酸处理改变的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验